Personal profile


Changhai Ding is a Professor at University of Tasmanian, Associate Director (International) of Menzies Institute for Medical Research, an Adjunct Professor at Monash University, and an Honorary Professor at the University of Sydney.  He is currently a Professor at Southern Medical University, an Adjunct Professor and Director of Arthritis Research Institute at Anhui Medical University, and a Guest Professor at Xi’an Jiaotong University and Shanghai University of TCM, China. He received a MBBS degree in 1990, a Masters degree in 1993 and a PhD degree in 1999 in Anhui Medical University. From 2001 to 2004, he studied clinical epidemiology in Menzies Institute for Medical Research at the University of Tasmania as a post-doctoral fellow. Since then he has been working in Menzies Institute for Medical Research. He has jointed Monash University as a Senior Research Fellow in 2009, as an Associate Adjunct Professor in 2012, and an Adjunct Professor in 2016.
Prof Ding has focused on the epidemiological and clinical studies in osteoarthritis and osteoporosis for more than 15 years. His research has been supported by Australia Research Council (ARC), NHMRC, and the National Natural Science Foundation of China. He has received grants from competitive sources totally over 4.2 million dollars, and has published over 160 manuscripts in international peer-reviewed journals including *JAMA*, *JAMA Internal Medicine*, *Annals of the Rheumatic Diseases*, *Arthritis & Rheumatology* and *Journal of the American College of Cardiology* with an H index of 35.
Dr. Ding’s team developed the classification system of knee cartilage defects, and scoring methodologies for subchondral bone density, effusion-synovitis and Haffa synovitis. These have been essential tools in this research field. He identified that vitamin D deficiency played a role in knee osteoarthritis, metabolic inflammation was involved in the pathogenesis of osteoarthritis, Hoffa’s fat pad played a role in the development and progression of knee osteoarthritis, and decreased bone mineral density was associated with increased loss of cartilage in osteoarthritis. He has proposed possible interventions on osteoarthritis in the early and mid- stages.
Dr. Ding was awarded the 1999 Servier Young Investigator Prize in Pharmacology by the Chinese Pharmacological Society and the Servier Institute (France). He was the winner of “Rising Star” by University of Tasmania in 2008, Career Development Award by NHMRC (Level 2, 2008-2011) Future Fellowship by ARC in 2012 "Ten of the Best Research Projects 2013" by NHMRC, and “Wan Jiang Scholar” by Anhui Provincial Government in 2015.
Dr. Ding is a Vice-President of Australia Chinese Association for Biomedical Sciences (ACABS), Chairman of ACABS Tasmania Branch, President of Melbourne Anhui Association, and Vice President of Tasmania Chinese Professionals Association. He is a member of Research and Education Committee, Osteoarthritis Research Society International (OARSI). He is a Deputy Section Editor for *BMC Musculoskeletal Disorders*, an Associate Editor for *Reviews on Recent Clinical Trials*, and an Editorial Board Member for *Arthritis Research & Therapy* and other 7 international journals. He is a peer reviewer for > 30 international journals including *Lancet, JAMA, BMJ,* *Annals of the Rheumatic Diseases* and *Arthritis & Rheumatism*.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or